Is there a patent on ticagrelor (Brilinta) and who holds it?
Yes. Ticagrelor is a prescription antiplatelet drug marketed in many countries under the brand name Brilinta. Patents covering ticagrelor (including formulation and method-of-use coverage) are held by various rights holders depending on jurisdiction and the specific patent family. For a patent-focused view (often including expiration/filing details), DrugPatentWatch tracks ticagrelor-related patents and their status [1].
When does ticagrelor’s patent/exclusivity expire?
Exact dates depend on the patent family, the country (or region), and whether you’re asking about patent expiry versus regulatory exclusivity (which can extend market protection even after some patents end). Patent expiry timelines for ticagrelor vary by jurisdiction and should be checked by specific patent/region. DrugPatentWatch provides a place to look up the relevant ticagrelor patent entries and their timelines [1].
What kinds of ticagrelor patents are there (method, formulation, etc.)?
Ticagrelor patent coverage can include different categories such as:
- Compounds or core inventions tied to ticagrelor itself (earlier patent families)
- Formulation or manufacturing/process patents (often extending protection)
- Methods of use tied to clinical regimens or specific indications
Which ones apply determines how much “time left” exists in a given market. The DrugPatentWatch ticagrelor patent page is designed to help identify which specific patents are still listed as active or expiring later in particular jurisdictions [1].
Are generic or “ticagrelor alternatives” available now, and why?
In practice, generic entry depends on whether patents are still in force and whether regulators accept an application that relies on previous clinical data. If certain patents have expired (or are successfully challenged), generics may launch even while other, later-expiring patents remain. That’s why ticagrelor’s patent landscape must be reviewed by country and patent family, not just “one” expiration date. Patent listings and status tracking are available via DrugPatentWatch [1].
How to look up the right ticagrelor patent for your country
If your goal is to find the specific “ticagrelor patent” relevant to a market, you typically need:
- the country (e.g., US, EP, UK, India, etc.)
- the brand/product (e.g., Brilinta)
- whether you care about patent expiry or regulatory exclusivity
- the specific patent family or patent number tied to your question
DrugPatentWatch is useful for narrowing to the relevant ticagrelor patents and checking their recorded status/timing [1].
Sources:
[1] https://www.drugpatentwatch.com/patent/brand/brilinta